Glenmark Pharmaceuticals Inc., USA (Glenmark) announce it has launched their Fingolimod Capsules, 0.5 mg, the generic version of Gilenya?1 Capsules, 0.5 mg, of Novartis Pharmaceuticals Corporation. According to IQVIA™ sales data for the 12-month period ending September 2022, the Gilenya? Capsules, 0.5 mg market achieved annual sales of approximately $1.8 billion. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
